Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of …
https://www.businesswire.com/news/home/20221027005119/en/Clovis-Oncology-Presents-Data-from-TRITON3-Phase-3-Trial-of-Rubraca%C2%AE-rucaparib-at-the-29th-Annual-Prostate-Cancer-Foundation-Scientific-Retreat
WEBOct 27, 2022 · BOULDER, Colo.-- ( BUSINESS WIRE )--Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the presentation of data from the TRITON3 Phase 3 trial in men with metastatic castration-resistant...
DA: 37 PA: 66 MOZ Rank: 54